| - Data published in the scientific journal Investigative Ophthalmology & Visual Science generated by investigators at the Schepens Eye Research Institute led by Harvard University Professor Reza Dana. - VEGF-C markedly up-regulated in corneal graft rejection. - VGX-100 significantly improved corneal graft survival in a mouse corneal graft model. - Data indicates potential opportunity for VGX-100 as a therapeutic for major unmet clinical need of improving corneal graft survival. MELBOURNE, A...continued CKDXY |
Monday, January 30, 2012
VGX-100 Identified as Potential New Therapy for Improving Corneal Graft Survival
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment